Tenet Healthcare (THC) Tops Q2 EPS by 31c, Offers Q3 & FY Guidance

Tenet Healthcare (NYSE: THC) reported Q2 EPS of $0.75, $0.31 better than the analyst estimate of $0.44. Revenue for the quarter came in at $4.49 billion versus the consensus estimate of $4.4 billion.

• Generated Adjusted EBITDA of $568 million

Tenet Healthcare sees FY2015 EPS of $1.32-$2.21, versus the consensus of $2.29. Tenet Healthcare sees FY2015 revenue of $18.1-18.5 billion, versus the consensus of $18 billion.

• Adjusted EBITDA of $2.225 billion to $2.325 billion

Tenet Healthcare sees Q3 2015 EPS of $0.05-$0.49, versus the consensus of $0.40. Tenet Healthcare sees Q3 2015 revenue of $4.65-4.85 billion.

• Adjusted EBITDA of $550 million to $600 million

For earnings history and earnings-related data on Tenet Healthcare (THC) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Nucor projects Q3 2026 earnings above prior year, below estimates
• Wells Fargo cuts Netflix rating on engagement risk, weak slate